{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:34:38Z","timestamp":1792229678812,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2320-B-006 -046 -MY3"],"award-info":[{"award-number":["NSTC 111-2320-B-006 -046 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2320-B-006 -046 -MY3"],"award-info":[{"award-number":["NSTC 111-2320-B-006 -046 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2320-B-006 -046 -MY3"],"award-info":[{"award-number":["NSTC 111-2320-B-006 -046 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2320-B-006 -046 -MY3"],"award-info":[{"award-number":["NSTC 111-2320-B-006 -046 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-006 -043 -MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-006 -043 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2320-B-006 -046 -MY3"],"award-info":[{"award-number":["NSTC 111-2320-B-006 -046 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12602-025-10556-9","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:59:25Z","timestamp":1746500365000},"page":"2461-2475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lactiplantibacillus plantarum GMNL-661 Ameliorates Clostridioides difficile Infection and Reconfigures Intestinal Microbiota in a Murine Model"],"prefix":"10.1007","volume":"17","author":[{"given":"Meng-Jia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhen-Wei","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenn-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hua","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-9839","authenticated-orcid":false,"given":"Pei-Jane","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"10","key":"10556_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrmicro.2016.108","volume":"14","author":"MC Abt","year":"2016","unstructured":"Abt MC, McKenney PT, Pamer EG (2016) Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol 14(10):609\u2013620. https:\/\/doi.org\/10.1038\/nrmicro.2016.108","journal-title":"Nat Rev Microbiol"},{"issue":"24","key":"10556_CR2","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1056\/NEJMc1505190","volume":"372","author":"N Banaei","year":"2015","unstructured":"Banaei N, Anikst V, Schroeder LF (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372(24):2368\u20132369. https:\/\/doi.org\/10.1056\/NEJMc1505190","journal-title":"N Engl J Med"},{"issue":"9","key":"10556_CR3","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1128\/JCM.02437-07","volume":"46","author":"H Martin","year":"2008","unstructured":"Martin H et al (2008) Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol 46(9):2999\u20133004. https:\/\/doi.org\/10.1128\/JCM.02437-07","journal-title":"J Clin Microbiol"},{"issue":"14","key":"10556_CR4","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","volume":"382","author":"AY Guh","year":"2020","unstructured":"Guh AY et al (2020) Trends in U.S. Burden of Clostridioides difficile infection and outcomes. N Engl J Med 382(14):1320\u20131330. https:\/\/doi.org\/10.1056\/NEJMoa1910215","journal-title":"N Engl J Med"},{"issue":"10","key":"10556_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10096-007-0355-8","volume":"26","author":"E Sawabe","year":"2007","unstructured":"Sawabe E et al (2007) Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 26(10):695\u2013703. https:\/\/doi.org\/10.1007\/s10096-007-0355-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10556_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jmii.2021.01.003","volume":"54","author":"RF Zhang","year":"2021","unstructured":"Zhang RF et al (2021) Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital. J Microbiol Immunol Infect 54(6):1179\u20131183. https:\/\/doi.org\/10.1016\/j.jmii.2021.01.003","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10556_CR7","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.2807\/esm.12.06.00714-en","volume":"12","author":"EJ Kuijper","year":"2007","unstructured":"Kuijper EJ et al (2007) Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12(6):E1-2","journal-title":"Euro Surveill"},{"issue":"4","key":"10556_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jhin.2018.01.015","volume":"99","author":"E Ofori","year":"2018","unstructured":"Ofori E et al (2018) Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect 99(4):436\u2013442. https:\/\/doi.org\/10.1016\/j.jhin.2018.01.015","journal-title":"J Hosp Infect"},{"issue":"6","key":"10556_CR9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jmii.2020.07.012","volume":"54","author":"JC Lee","year":"2020","unstructured":"Lee JC et al (2020) Severe Clostridium difficile infections in intensive care units: diverse clinical presentations. J Microbiol Immunol Infect 54(6):1111\u20131117. https:\/\/doi.org\/10.1016\/j.jmii.2020.07.012","journal-title":"J Microbiol Immunol Infect"},{"key":"10556_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.anaerobe.2016.06.002","volume":"41","author":"BY Tsai","year":"2016","unstructured":"Tsai BY et al (2016) Zoonotic potential of the Clostridium difficile RT078 family in Taiwan. Anaerobe 41:125\u2013130. https:\/\/doi.org\/10.1016\/j.anaerobe.2016.06.002","journal-title":"Anaerobe"},{"key":"10556_CR11","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2147\/IDR.S162874","volume":"11","author":"YP Hung","year":"2018","unstructured":"Hung YP et al (2018) Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan. Infect Drug Resist 11:1197\u20131203. https:\/\/doi.org\/10.2147\/IDR.S162874","journal-title":"Infect Drug Resist"},{"key":"10556_CR12","doi-asserted-by":"publisher","unstructured":"Tsai CS et al (2021) Clostridioides difficile infection: an emerging zoonosis? Expert Rev Anti Infect Ther:1\u201310. https:\/\/doi.org\/10.1080\/14787210.2021.1967746","DOI":"10.1080\/14787210.2021.1967746"},{"issue":"5","key":"10556_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/ciab718","volume":"73","author":"S Johnson","year":"2021","unstructured":"Johnson S et al (2021) Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for healthcare Epidemiology of America (shea): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis 73(5):755\u2013757. https:\/\/doi.org\/10.1093\/cid\/ciab718","journal-title":"Clin Infect Dis"},{"issue":"Suppl 6","key":"10556_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1469-0691.12046","volume":"18","author":"CP Kelly","year":"2012","unstructured":"Kelly CP (2012) Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 18(Suppl 6):21\u201327. https:\/\/doi.org\/10.1111\/1469-0691.12046","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10556_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S1473-3099(17)30751-X","volume":"18","author":"B Guery","year":"2018","unstructured":"Guery B et al (2018) Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial. Lancet Infect Dis 18(3):296\u2013307. https:\/\/doi.org\/10.1016\/S1473-3099(17)30751-X","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10556_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","volume":"376","author":"MH Wilcox","year":"2017","unstructured":"Wilcox MH et al (2017) Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 376(4):305\u2013317. https:\/\/doi.org\/10.1056\/NEJMoa1602615","journal-title":"N Engl J Med"},{"issue":"5","key":"10556_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407\u2013415. https:\/\/doi.org\/10.1056\/NEJMoa1205037","journal-title":"N Engl J Med"},{"issue":"1","key":"10556_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.idc.2014.11.009","volume":"29","author":"K Rao","year":"2015","unstructured":"Rao K, Young VB (2015) Fecal microbiota transplantation for the management of Clostridium difficile infection. Infect Dis Clin North Am 29(1):109\u2013122. https:\/\/doi.org\/10.1016\/j.idc.2014.11.009","journal-title":"Infect Dis Clin North Am"},{"issue":"21","key":"10556_CR19","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z et al (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381(21):2043\u20132050. https:\/\/doi.org\/10.1056\/NEJMoa1910437","journal-title":"N Engl J Med"},{"key":"10556_CR20","doi-asserted-by":"publisher","unstructured":"Quemeneur L et al (2018) Clostridium difficile toxoid vaccine candidate confers broad protection against a range of prevalent circulating strains in a nonclinical setting. Infect Immun 86(6). https:\/\/doi.org\/10.1128\/IAI.00742-17","DOI":"10.1128\/IAI.00742-17"},{"issue":"3","key":"10556_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0168-1605(97)00136-0","volume":"39","author":"F Guarner","year":"1998","unstructured":"Guarner F, Schaafsma GJ (1998) Probiotics. Int J Food Microbiol 39(3):237\u2013238. https:\/\/doi.org\/10.1016\/s0168-1605(97)00136-0","journal-title":"Int J Food Microbiol"},{"issue":"8","key":"10556_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR et al (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.75","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10556_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.copbio.2016.11.010","volume":"44","author":"ML Marco","year":"2017","unstructured":"Marco ML et al (2017) Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 44:94\u2013102. https:\/\/doi.org\/10.1016\/j.copbio.2016.11.010","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10556_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4315\/0362-028X.JFP-18-303","volume":"82","author":"Z Gao","year":"2019","unstructured":"Gao Z et al (2019) Inhibitory effect of lactic acid bacteria on foodborne pathogens: a review. J Food Prot 82(3):441\u2013453. https:\/\/doi.org\/10.4315\/0362-028X.JFP-18-303","journal-title":"J Food Prot"},{"issue":"2","key":"10556_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MCG.0b013e3181b2683f","volume":"44","author":"E Lonnermark","year":"2010","unstructured":"Lonnermark E et al (2010) Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol 44(2):106\u2013112. https:\/\/doi.org\/10.1097\/MCG.0b013e3181b2683f","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10556_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2012.8735","volume":"308","author":"EJ Videlock","year":"2012","unstructured":"Videlock EJ, Cremonini F (2012) Probiotics for antibiotic-associated diarrhea. JAMA 308(7):665. https:\/\/doi.org\/10.1001\/jama.2012.8735. (author reply 665-6)","journal-title":"JAMA"},{"issue":"8","key":"10556_CR27","doi-asserted-by":"publisher","first-page":"e043054","DOI":"10.1136\/bmjopen-2020-043054","volume":"11","author":"C Goodman","year":"2021","unstructured":"Goodman C et al (2021) Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open 11(8):e043054. https:\/\/doi.org\/10.1136\/bmjopen-2020-043054","journal-title":"BMJ Open"},{"key":"10556_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-024-10287-3","author":"A Aljohani","year":"2024","unstructured":"Aljohani A et al (2024) The health benefits of probiotic Lactiplantibacillus plantarum: a systematic review and meta-analysis. Probiotics Antimicrob Proteins. https:\/\/doi.org\/10.1007\/s12602-024-10287-3","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"10556_CR29","doi-asserted-by":"publisher","first-page":"e0162522","DOI":"10.1128\/spectrum.01625-22","volume":"10","author":"HI Ko","year":"2022","unstructured":"Ko HI et al (2022) Optimizing conditions in the acid tolerance test for potential probiotics using response surface methodology. Microbiol Spectr 10(4):e0162522. https:\/\/doi.org\/10.1128\/spectrum.01625-22","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10556_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s13213-017-1254-6","volume":"67","author":"Y Feng","year":"2017","unstructured":"Feng Y et al (2017) Potential probiotic properties of lactic acid bacteria isolated from the intestinal mucosa of healthy piglets. Ann Microbiol 67(3):239\u2013253. https:\/\/doi.org\/10.1007\/s13213-017-1254-6","journal-title":"Ann Microbiol"},{"key":"10556_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.anaerobe.2013.02.006","volume":"20","author":"A Schoster","year":"2013","unstructured":"Schoster A et al (2013) In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe 20:36\u201341. https:\/\/doi.org\/10.1016\/j.anaerobe.2013.02.006","journal-title":"Anaerobe"},{"issue":"4","key":"10556_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/infdis\/jiv184","volume":"212","author":"YP Hung","year":"2015","unstructured":"Hung YP et al (2015) Proton-pump inhibitor exposure aggravates Clostridium difficile-associated colitis: evidence from a mouse model. J Infect Dis 212(4):654\u2013663. https:\/\/doi.org\/10.1093\/infdis\/jiv184","journal-title":"J Infect Dis"},{"issue":"1","key":"10556_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41420-023-01455-5","volume":"9","author":"R Chen","year":"2023","unstructured":"Chen R et al (2023) Serum amyloid protein A in inflammatory bowel disease: from bench to bedside. Cell Death Discovery 9(1):154. https:\/\/doi.org\/10.1038\/s41420-023-01455-5","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10556_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1757-4749-2-19","volume":"2","author":"IM Carroll","year":"2010","unstructured":"Carroll IM et al (2010) Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2(1):19. https:\/\/doi.org\/10.1186\/1757-4749-2-19","journal-title":"Gut Pathog"},{"issue":"4","key":"10556_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"10556_CR36","doi-asserted-by":"publisher","unstructured":"Ward T et al (2017) BugBase predicts organism-level microbiome phenotypes. bioRxiv:133462. https:\/\/doi.org\/10.1101\/133462","DOI":"10.1101\/133462"},{"issue":"6","key":"10556_CR37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/bioinformatics\/btx713","volume":"34","author":"Y Tanizawa","year":"2017","unstructured":"Tanizawa Y, Fujisawa T, Nakamura Y (2017) DFAST: a flexible prokaryotic genome annotation pipeline for faster genome publication. Bioinformatics 34(6):1037\u20131039. https:\/\/doi.org\/10.1093\/bioinformatics\/btx713","journal-title":"Bioinformatics"},{"issue":"D1","key":"10556_CR38","doi-asserted-by":"publisher","first-page":"D285","DOI":"10.1093\/nar\/gky1030","volume":"47","author":"JH Jhong","year":"2019","unstructured":"Jhong JH et al (2019) dbAMP: an integrated resource for exploring antimicrobial peptides with functional activities and physicochemical properties on transcriptome and proteome data. Nucleic Acids Res 47(D1):D285-d297. https:\/\/doi.org\/10.1093\/nar\/gky1030","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"10556_CR39","doi-asserted-by":"publisher","first-page":"W20","DOI":"10.1093\/nar\/gkh435","volume":"32","author":"S McGinnis","year":"2004","unstructured":"McGinnis S, Madden TL (2004) BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 32(Web Server issue):W20-5. https:\/\/doi.org\/10.1093\/nar\/gkh435","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10556_CR40","doi-asserted-by":"publisher","first-page":"D690","DOI":"10.1093\/nar\/gkac920","volume":"51","author":"BP Alcock","year":"2023","unstructured":"Alcock BP et al (2023) CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res 51(D1):D690-d699. https:\/\/doi.org\/10.1093\/nar\/gkac920","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"10556_CR41","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gki008","volume":"33","author":"L Chen","year":"2005","unstructured":"Chen L et al (2005) VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res 33(Database issue):D325-8. https:\/\/doi.org\/10.1093\/nar\/gki008","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10556_CR42","doi-asserted-by":"publisher","first-page":"e06506","DOI":"10.2903\/j.efsa.2021.6506","volume":"19","author":"Authority EFS","year":"2021","unstructured":"Authority EFS (2021) EFSA statement on the requirements for whole genome sequence analysis of microorganisms intentionally used in the food chain. EFSA J 19(7):e06506. https:\/\/doi.org\/10.2903\/j.efsa.2021.6506","journal-title":"EFSA J"},{"issue":"12","key":"10556_CR43","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.3390\/nu7125526","volume":"7","author":"A Kujawa-Szewieczek","year":"2015","unstructured":"Kujawa-Szewieczek A et al (2015) The effect of Lactobacillus plantarum 299v on the incidence of Clostridium difficile infection in high risk patients treated with antibiotics. Nutrients 7(12):10179\u201310188. https:\/\/doi.org\/10.3390\/nu7125526","journal-title":"Nutrients"},{"key":"10556_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-319-72799-8_9","volume":"1050","author":"P Spigaglia","year":"2018","unstructured":"Spigaglia P, Mastrantonio P, Barbanti F (2018) Antibiotic resistances of Clostridium difficile. Adv Exp Med Biol 1050:137\u2013159. https:\/\/doi.org\/10.1007\/978-3-319-72799-8_9","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10556_CR45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1080\/22221751.2019.1682472","volume":"8","author":"Y Luo","year":"2019","unstructured":"Luo Y et al (2019) Different molecular characteristics and antimicrobial resistance profiles of Clostridium difficile in the Asia-Pacific region. Emerg Microbes Infect 8(1):1553\u20131562. https:\/\/doi.org\/10.1080\/22221751.2019.1682472","journal-title":"Emerg Microbes Infect"},{"key":"10556_CR46","doi-asserted-by":"publisher","first-page":"102136","DOI":"10.1016\/j.anaerobe.2019.102136","volume":"61","author":"F Barbanti","year":"2020","unstructured":"Barbanti F, Spigaglia P (2020) Microbiological characteristics of human and animal isolates of Clostridioides difficile in Italy: results of the Istituto Superiore di Sanita in the years 2006\u20132016. Anaerobe 61:102136. https:\/\/doi.org\/10.1016\/j.anaerobe.2019.102136","journal-title":"Anaerobe"},{"issue":"16","key":"10556_CR47","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT (2015) Clostridium difficile infection. N Engl J Med 372(16):1539\u20131548. https:\/\/doi.org\/10.1056\/NEJMra1403772","journal-title":"N Engl J Med"},{"key":"10556_CR48","doi-asserted-by":"publisher","unstructured":"Bratkovic T et al (2024) New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation. Gut Microbes 16(1). https:\/\/doi.org\/10.1080\/19490976.2024.2337312","DOI":"10.1080\/19490976.2024.2337312"},{"issue":"12","key":"10556_CR49","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1093\/cid\/ciaa387","volume":"72","author":"BH McGovern","year":"2021","unstructured":"McGovern BH et al (2021) SER-109, an investigational microbiome drug to reduce recurrence after Clostridioides difficile infection: lessons learned from a phase 2 trial. Clin Infect Dis 72(12):2132\u20132140. https:\/\/doi.org\/10.1093\/cid\/ciaa387","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10556_CR50","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","volume":"67","author":"I Castagliuolo","year":"1999","unstructured":"Castagliuolo I et al (1999) Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 67(1):302\u2013307. https:\/\/doi.org\/10.1128\/IAI.67.1.302-307.1999","journal-title":"Infect Immun"},{"issue":"1","key":"10556_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.anaerobe.2011.11.002","volume":"18","author":"P Carasi","year":"2012","unstructured":"Carasi P et al (2012) Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins. Anaerobe 18(1):135\u2013142. https:\/\/doi.org\/10.1016\/j.anaerobe.2011.11.002","journal-title":"Anaerobe"},{"issue":"8","key":"10556_CR52","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1399-6576.2008.01748.x","volume":"52","author":"B Klarin","year":"2008","unstructured":"Klarin B et al (2008) Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiol Scand 52(8):1096\u20131102. https:\/\/doi.org\/10.1111\/j.1399-6576.2008.01748.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"10556_CR53","doi-asserted-by":"publisher","unstructured":"Jeng HS and Yan TR (2022) Lactiplantibacillus plantarum E51 protects against Clostridioides difficile-induced damages on Caco-2 intestinal barrier functions. Arch Microbiol 204(6). https:\/\/doi.org\/10.1007\/s00203-022-02837-6","DOI":"10.1007\/s00203-022-02837-6"},{"issue":"3","key":"10556_CR54","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1128\/iai.69.3.1329-1336.2001","volume":"69","author":"A Nusrat","year":"2001","unstructured":"Nusrat A et al (2001) Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 69(3):1329\u20131336. https:\/\/doi.org\/10.1128\/iai.69.3.1329-1336.2001","journal-title":"Infect Immun"},{"key":"10556_CR55","doi-asserted-by":"publisher","first-page":"986457","DOI":"10.3389\/fmicb.2022.986457","volume":"13","author":"YH Lai","year":"2022","unstructured":"Lai YH et al (2022) Peroxisome proliferator-activated receptor-\u03b3 as the gatekeeper of tight junction in Clostridioides difficile infection. Front Microbiol 13:986457. https:\/\/doi.org\/10.3389\/fmicb.2022.986457","journal-title":"Front Microbiol"},{"issue":"1","key":"10556_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pathogens2010055","volume":"2","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Khan WI (2013) Goblet cells and mucins: role in innate defense in enteric infections. Pathogens 2(1):55\u201370. https:\/\/doi.org\/10.3390\/pathogens2010055","journal-title":"Pathogens"},{"issue":"7533","key":"10556_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie CG et al (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517(7533):205\u2013208. https:\/\/doi.org\/10.1038\/nature13828","journal-title":"Nature"},{"issue":"7461","key":"10556_CR58","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi K et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500(7461):232\u2013236. https:\/\/doi.org\/10.1038\/nature12331","journal-title":"Nature"},{"issue":"1","key":"10556_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.micinf.2015.09.008","volume":"18","author":"S Gu","year":"2016","unstructured":"Gu S et al (2016) Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes Infect 18(1):30\u201338. https:\/\/doi.org\/10.1016\/j.micinf.2015.09.008","journal-title":"Microbes Infect"},{"key":"10556_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.anaerobe.2016.05.006","volume":"41","author":"CL Ross","year":"2016","unstructured":"Ross CL, Spinler JK, Savidge TC (2016) Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe 41:37\u201343. https:\/\/doi.org\/10.1016\/j.anaerobe.2016.05.006","journal-title":"Anaerobe"},{"key":"10556_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2015.03.008","volume":"34","author":"LH Zhang","year":"2015","unstructured":"Zhang LH et al (2015) Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization. Anaerobe 34:1\u20137. https:\/\/doi.org\/10.1016\/j.anaerobe.2015.03.008","journal-title":"Anaerobe"},{"issue":"3","key":"10556_CR62","doi-asserted-by":"publisher","first-page":"e1009348","DOI":"10.1371\/journal.ppat.1009348","volume":"17","author":"LR Frost","year":"2021","unstructured":"Frost LR, Cheng JKJ, Unnikrishnan M (2021) Clostridioides difficile biofilms: a mechanism of persistence in the gut? PLoS Pathog 17(3):e1009348. https:\/\/doi.org\/10.1371\/journal.ppat.1009348","journal-title":"PLoS Pathog"},{"issue":"4","key":"10556_CR63","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1086\/318130","volume":"31","author":"CM Surawicz","year":"2000","unstructured":"Surawicz CM et al (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31(4):1012\u20131017. https:\/\/doi.org\/10.1086\/318130","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10556_CR64","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/jam.12249","volume":"115","author":"AS Dhanani","year":"2013","unstructured":"Dhanani AS, Bagchi T (2013) The expression of adhesin EF-Tu in response to mucin and its role in Lactobacillus adhesion and competitive inhibition of enteropathogens to mucin. J Appl Microbiol 115(2):546\u2013554. https:\/\/doi.org\/10.1111\/jam.12249","journal-title":"J Appl Microbiol"},{"key":"10556_CR65","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3389\/fmicb.2019.02351","volume":"10","author":"KL Harvey","year":"2019","unstructured":"Harvey KL et al (2019) The diverse functional roles of elongation factor Tu (EF-Tu) in microbial pathogenesis. Front Microbiol 10:2351. https:\/\/doi.org\/10.3389\/fmicb.2019.02351","journal-title":"Front Microbiol"},{"key":"10556_CR66","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1475-2859-11-116","volume":"11","author":"G Deepika","year":"2012","unstructured":"Deepika G et al (2012) Influence of fermentation conditions on the surface properties and adhesion of Lactobacillus rhamnosus GG. Microb Cell Fact 11:116. https:\/\/doi.org\/10.1186\/1475-2859-11-116","journal-title":"Microb Cell Fact"},{"key":"10556_CR67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-2859-8-14","volume":"8","author":"C Castaldo","year":"2009","unstructured":"Castaldo C et al (2009) Surface displaced alfa-enolase of Lactobacillus plantarum is a fibronectin binding protein. Microb Cell Fact 8:14. https:\/\/doi.org\/10.1186\/1475-2859-8-14","journal-title":"Microb Cell Fact"},{"key":"10556_CR68","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1475-2859-11-149","volume":"11","author":"DM Remus","year":"2012","unstructured":"Remus DM et al (2012) Impact of 4 Lactobacillus plantarum capsular polysaccharide clusters on surface glycan composition and host cell signaling. Microb Cell Fact 11:149. https:\/\/doi.org\/10.1186\/1475-2859-11-149","journal-title":"Microb Cell Fact"},{"issue":"10","key":"10556_CR69","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1128\/aem.71.10.5794-5804.2005","volume":"71","author":"MA Azcarate-Peril","year":"2005","unstructured":"Azcarate-Peril MA et al (2005) Microarray analysis of a two-component regulatory system involved in acid resistance and proteolytic activity in Lactobacillus acidophilus. Appl Environ Microbiol 71(10):5794\u20135804. https:\/\/doi.org\/10.1128\/aem.71.10.5794-5804.2005","journal-title":"Appl Environ Microbiol"},{"key":"10556_CR70","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/1471-2164-13-533","volume":"13","author":"JR Broadbent","year":"2012","unstructured":"Broadbent JR et al (2012) Analysis of the Lactobacillus casei supragenome and its influence in species evolution and lifestyle adaptation. BMC Genomics 13:533. https:\/\/doi.org\/10.1186\/1471-2164-13-533","journal-title":"BMC Genomics"},{"issue":"3","key":"10556_CR71","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12602-017-9285-7","volume":"10","author":"NM Mansour","year":"2018","unstructured":"Mansour NM et al (2018) Inhibition of Clostridium difficile in mice using a mixture of potential probiotic strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel candidates to control C. difficile infection. Probiotics Antimicrob Proteins 10(3):511\u2013522. https:\/\/doi.org\/10.1007\/s12602-017-9285-7","journal-title":"Probiotics Antimicrob Proteins"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10556-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:22:38Z","timestamp":1757164958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10556"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10556-9","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"21 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}